![](https://www.biospectrumasia.com/uploads/articles/invest-24623.jpg)
Korea's SK bioscience invests $2 M in US biotech startup Sunflower Therapeutics
SK bioscience, a global innovative vaccine and biotech company based in South Korea, has signed a Simple Agreement for Future Equity (SAFE) totaling $2 million (KRW 2.78 billion) with Sunflower Therapeutics, a US-based biotech startup. Founded in 2018, …